Tags: Drug.

Sonidegib (INN) or erismodegib (USAN) also known as LDE225 is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) being developed as an anticancer agent by Novartis.

Sonidegib2DACS.svg
IUPAC name
N-[6-[(2S6R)-26-Dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
PubChem
135626837

Loading...

This page contains content from the copyrighted Wikipedia article "Sonidegib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.